The American Cancer Society updated its lung cancer screening guidelines for the first time in a decade, with the goal of reducing deaths from disease due to smoking history.

Access to care, eliminating disparities and expanding quality care are the top three things leaders want changed about cancer care.

The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients. 

Minneapolis-based Allina Health Cancer Institute is launching a first-of-its-kind clinical trial using artificial intelligence and a simple blood draw to find and diagnose cancer.

A study found oncologists who receive industry payments might be more likely to provide non-recommended and low-value treatment to cancer patients.

Safe handling of chemotherapy drugs is challenging but essential for oncology centers

Sixteen hospitals and health systems have been recognized for excellence in oncology by patients and providers, according to the WebMD Choice Awards.

Sacramento, Calif.-based Sutter Health and pharmaceutical giant AstraZeneca will launch an app this winter to help cancer patients manage and track chemotherapy drugs more easily. 

President Joe Biden awarded immunotherapy pioneer and longtime oncology physician Steven Rosenberg, MD, PhD, the National Medal of Technology and Innovation on Oct. 24. 

About 60% of newly diagnosed cancer patients made at least one visit to the emergency department for symptoms, but only half of those resulted in hospitalization, a UT Southwestern's Simmons Cancer Center study found.

About 52% of oncologists reported experiencing burnout, according to a 2023 Medscape report.

It is possible to detect and treat dormant breast cancer cells, researchers at the University of Pennsylvania's Perelman School of Medicine and the Abramson Cancer Center found. 

A recent study reduced the risk of disease progression or death by 55% in bladder cancer patients with a new combination of drugs, CNN reported Oct. 22.

A study from Boston-based Mass General Cancer Center found carcinogens can increase cancer cells' susceptibility to immune attack.

Rochester, Minn.-based Mayo Clinic has entered into a multiyear partnership with U.K.-based company Oxford Nanopore to explore genetic predispositions to cancer.

New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release. 

Here are nine systems and organizations developing artificial intelligence models to find and treat cancer faster:

Julie Gralow, MD, was named Woman Oncologist of the Year by Women Leaders in Oncology.

U.S. News & World Report evaluated 899 hospitals across the country and ranked them for treating leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers.

Even though a majority of breast cancer cases are diagnosed without a lump that can be detected, less than half recognize other symptoms often associated with it, according to new research from the Ohio State University Comprehensive Cancer Center.